| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |